Dermavant Sciences Gmbh

Lindy Biosciences, Inc.

Michael Quinn Doherty

Jon Lenn

Joey Roger Thomas

Leandro Santos

Justin Whiteman

Mary Bedard

Piyush Jain

Deborah Lee Bitterfield

Jon D Lenn

Justin E Whiteman

Leandro L Santos

Described herein are isolated cell culture components such as, e.g., biologics and/or lipids, and methods for isolating cell culture components from a liquid cell culture medium. Methods of the present invention may include contacting a dehydration composition and a liquid cell culture medium comprising a target component to form a mixture; forming an at least partially dehydrated component in the mixture; and separating the at least partially dehydrated component from the mixture, thereby providing an isolated component. In some embodiments, the isolated component comprises the at least partially dehydrated component. In some embodiments, the isolated component is present in a composition (e.g., liquid phase) separated from the at least partially dehydrated component.

Compositions comprising solid particles

The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Topical pharmaceutical compositions

Growing community of inventors

Hillsborough, NC, United States of America

Michael Quinn Doherty